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doi:10.1016/j.jtcvs.2004.02.010TIn this month’s edition of the Journal, Syeda and colleagues1 report theresults of a meta-analysis performed on randomized experimental trials toassess the efficacy of coronary sinus retroperfusion by using intermittentcoronary sinus occlusion (ICSO) and synchronized retroperfusion (SRP) tosalvage acutely ischemic myocardium.In the ICSO technique a balloon-tipped catheter is positioned just beyond
the orifice of the coronary sinus, similar to the placement of a retrograde coronary
sinus cardioplegia catheter. The catheter is connected to a pneumatic pump that
automatically inflates and deflates the balloon according to a preset cycle. A cycle
of 10 seconds of inflation and 4 seconds of deflation was found to be the optimal
period to limit the increase of pressure in the coronary sinus. This allows for
sufficient drainage of coronary venous blood and avoids the complications of
hemorrhage, edema, thrombosis, and arrhythmias observed with prolonged increase
of coronary sinus pressure. This ability to limit peak coronary sinus pressure led to
the term pressure-controlled intermittent coronary sinus occlusion (PICSO). The
sudden occlusion of a coronary artery results in a significant decrease in coronary
sinus pressure. By increasing coronary sinus pressure, PICSO redistributes coronary
venous flow to jeopardized areas of the myocardium distal to an arterial occlusion.
The intermittent inflation-deflation cycle also enhances the washout of toxic me-
tabolites that form during periods of coronary occlusion and ischemia.
In contrast to PICSO, which displaces existing coronary venous blood, SRP
actively pumps arterial blood retrograde through the coronary sinus. In this tech-
nique a catheter is placed in the femoral artery, and arterial blood is withdrawn and
pumped into the coronary venous system during diastole through a catheter posi-
tioned into the coronary sinus. The meta-analysis by Syeda and colleagues1 of 7
experimental studies in which PICSO was performed during an acute coronary
occlusion revealed a 29% reduction in infarct size (P  .001), which increased to
39% when PICSO was combined with SRP. Our experimental studies, performed in
a porcine model of acute coronary occlusion with reperfusion on cardiopulmonary
bypass and cardioplegic arrest similar to urgent-emergency coronary artery bypass
graft (CABG) surgery, support these favorable effects of PICSO in salvaging
ischemic myocardium. PICSO enhanced the distribution of antegrade cardioplegia,2
improved regional wall motion and global left ventricular function,3 decreased
tissue acidosis,2,3 and decreased infarct size.4 When combined with percutaneous
bypass5 and intra-aortic balloon pump (IABP) support6 in the same model, PICSO
resulted in more complete reversal of ischemic damage than was observed from
each individual modality alone. Mohl and coworkers7 showed that PICSO could be
used clinically when they applied this technique in 15 patients undergoing mul-
tivessel CABG for 60 minutes during the reperfusion period. PICSO resulted in a
significant improvement in regional wall motion in segments that were previously
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mensional echocardiography.
The beneficial effects of PICSO and SRP in these exper-
imental studies prompted a renewed interest in coronary
retroperfusion by both cardiologists and surgeons as a
means to limit myocardial damage during acute coronary
syndromes. Patients with an acute myocardial infarction
(MI) or unstable angina arriving at a community hospital
could have the PICSO catheter inserted percutaneously
through the internal jugular vein and guided by means of
fluoroscopy into the coronary sinus. The initiation of PICSO
would provide some blood flow to the ischemic area of the
myocardium during transport to a tertiary referral center
with a cardiac catheterization laboratory. Catheterization
could then be performed to assess the coronary anatomy. If
a percutaneous procedure was to be performed, PICSO
could be used to administer antiarrhythmic agents, oxygen-
free radical scavengers, essential substrates, and thrombo-
lytic agents, which were found to be more effective when
delivered retrograde to jeopardized myocardium.8-11 If sur-
gical revascularization was necessary, the PICSO catheter
could be used during the period of cardioplegic arrest to
administer retrograde cardioplegia or improve the distribu-
tion of antegrade cardioplegia. PICSO also could be used to
stabilize patients in the catheterization laboratory after an
abrupt coronary occlusion during an attempted percutane-
ous transluminal coronary angioplasty. The IABP can help
to support the systemic circulation and unload the ventricle
but is limited in its ability to directly augment coronary
blood flow. PICSO can provide blood flow to areas of
jeopardized myocardium while the patient is transferred to
the operating room for emergency CABG surgery.
Despite these potentially clinically important applica-
tions of PICSO and SRP, the only form of retroperfusion
performed by cardiac surgeons today is retrograde coronary
sinus cardioplegia. Why have these other techniques failed
to emerge as useful therapeutic interventions for cardiolo-
gists and surgeons? SRP proved to be a cumbersome and
potentially dangerous technique in clinical practice. It re-
quired catheterization of the femoral artery, which is a
problem for patients with peripheral vascular disease. The
pneumatic pump designed for PICSO required only a simple
bellows mechanism. A more sophisticated pumping device
was required for SRP, where higher coronary sinus pres-
sures were more likely to be encountered because of the
direct infusion of blood into the coronary sinus during
diastole. Flow rates were critical with SRP and had to be
continuously monitored. Coronary sinus flow rates of less
than 50 mL/min resulted in poor results, yet flow rates of
greater than 200 mL/min might result in permanent damage
to the coronary sinus with thrombosis and ultimately steno-
sis and chronic myocardial edema. Although most studies
with SRP concentrated on treating left anterior descending
1550 The Journal of Thoracic and Cardiovascular Surgery ● Juncoronary artery occlusions, the effects of SRP on right
coronary and circumflex coronary artery occlusions were
not as well documented.
PICSO was a much easier technique to institute because
it did not require catheterization of the femoral artery and
results in only transient increases in coronary sinus pres-
sures, which were well tolerated. This technique did not
require the constant monitoring of inflation and deflation
seen with SRP. Why then was PICSO excluded from the
treatment of acute coronary syndromes? Although the mid-
1980s saw a renewed interest in retrograde coronary sinus
perfusion as a method to salvage acutely ischemic myocar-
dium, it also marked the introduction of antegrade percuta-
neous techniques to directly restore coronary blood beyond
an obstructing lesion. With the advancement in methodol-
ogy of angioplasty catheters, the use of bailout wires, the
development of glycoprotein 11b/IIIa receptor inhibitors,
and ultimately the introduction of stents, the interventional
cardiologist now had the means to directly augment coro-
nary artery blood flow. PICSO and SRP were now viewed
as palliative and temporizing techniques, as opposed to
therapeutic angioplasty, stents, and thrombolytics, which by
themselves could permanently revascularize the ischemic
myocardium. With improvements in these techniques came
a significant increase in procedural success and a concom-
itant reduction in complications, especially in the need for
emergency CABG. The reported rate of emergency CABG
for a failed percutaneous transluminal coronary angioplasty
is now less than 0.4%,12 and this was to have been a primary
indication for PICSO therapy. The introduction of stents
further diminished the potential role of PICSO as a support
device after a failed angioplasty. In our own institution, the
incidence of emergency CABG after a failed angioplasty in
the stent era decreased to less than 1%.13 More importantly,
there was a decrease in the incidence of abrupt coronary
occlusions as the primary indication for emergency opera-
tions from 76% to 11% (P  .0001). With stents now
available, the culprit vessel could remain open to allow
some antegrade flow to the area of jeopardized myocardium,
and the incidence of perioperative MIs decreased from 50%
to 19% (P  .02). CABG surgery could now be done in a
less urgent manner because the patients were now more
hemodynamically stable. This had a significant effect on
mortality for emergency CABG procedures after a failed
angioplasty, which decreased from 17.6% to 0% (P  .03)
in our own series.13
With the continued improvement of retrograde tech-
niques, the selection criteria for patients and lesions ame-
nable to percutaneous procedures broadened to include
high-risk patients with acute coronary syndromes and even
cardiogenic shock. Despite this, the need for CABG surgery
and possible PICSO intervention in these patients was fur-
14ther reduced and is now as low as 0.2%. In addition to the
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possible to perform these interventions more rapidly be-
cause more community hospitals began to open catheteriza-
tion laboratories. Hence ischemic times were now reduced
because patients were transferred to tertiary referral hospi-
tals less frequently.
The success of antegrade catheter technology prompted
industry to turn away from developing the methodology
necessary for PICSO. New PICSO catheters had to be
developed that could be safely inflated and deflated in the
coronary sinus 6 times per minute for possibly 24 to 48
hours. Faced with the choice of investing in the ever-
expanding, lucrative, therapeutic antegrade catheter market
versus the low-volume clinically uncharted waters of tem-
porizing and palliative PICSO therapy, the captains of in-
dustry chose the former, as did our cardiology colleagues.
Is there still a role for coronary sinus retroperfusion with
PICSO in the current therapy for acute coronary syndromes
and during cardiac surgery in our practices today? I believe
that there is for patients with acute MIs and patients under-
going beating-heart, off-pump CABG surgery. PICSO could
be a useful technique to salvage myocardium after acute
infarction. Despite the success of thrombolytic therapy and
acute angioplasty procedures, it is estimated that only a third
of patients presenting with an acute MI are eligible for
thrombolytic therapy.15 These patients will require transport
to the catheterization laboratory from either community
hospitals or their own facility where emergency percutane-
ous angioplasty or CABG might be required. It has been
documented that the interval from the presentation to the
emergency department to the actual angioplasty (down to
balloon time) is an independent predictor of 30-day mortal-
ity.16 PICSO might play an important role in preserving
myocardial viability and as a route to administer antiar-
rhythmics, thrombolytics, substrates, oxygen-free radical
scavengers, and inotropics for more effective distribution to
jeopardized myocardium. PICSO therapy is easy to initiate
and does not require peripheral arterial catheterization so
that patients with peripheral vascular disease can be in-
cluded. With the ever-increasing experience of coronary
sinus catheterization gained by electrophysiologists from
ablation procedures and pacemaker insertions, as well as
own experience with Heartport instrumentation, it is esti-
mated that PICSO therapy could be instituted in as little as
5 minutes. Furthermore, studies by Faxon and colleagues17
showed that diastolic coronary sinus occlusion pressure
correlated with left ventricular end-diastolic pressure.
Hence PICSO might also be used to monitor left ventricular
function during this critical period and avoid the extra time
needed to insert a Swan-Ganz catheter. Although PICSO
cannot independently support the systemic circulation, it
might also be used to stabilize patients with unstable angina
in the cardiac care unit who are unresponsive to medical
The Journal of Thoracicmanagement and are not candidates for IABP support. Un-
like the IABP, PICSO is effective even in the presence of
atrial and ventricular arrhythmias.
The second potential application for PICSO is as a car-
dioprotective technique during off-pump, beating-heart sur-
gery. Retroperfusion with PICSO might avoid or decrease
the amount of ischemia incurred during the time the coro-
nary artery vessels are occluded. It is uncertain as to what
the effect of tilting the heart in various positions will have
on the ability to achieve coronary venous retroperfusion.
Nevertheless, PICSO remains a potential technique to min-
imize ischemia during off-pump CABG surgery.
What will it take to introduce PICSO into clinical prac-
tice today? Industry must work with clinicians to develop
catheters that will safely inflate and deflate in the coronary
sinus for prolonged periods (24-48 hours). An easy way to
start is to use the current catheters available for coronary
sinus cardioplegia administration and make the necessary
modifications to prevent premature rupture. The pneumatic
pumps are already available and require no further alter-
ations. Prospective and clinical studies will need to be
designed comparing not only survival, enzyme leaks, and
electrocardiographic changes but also more sophisticated
diagnostic techniques, such as echocardiography, nuclear
magnetic resonance, and positron emission tomography
scanning to more accurately document and detect quantita-
tive changes in regional function and infarct size.
PICSO technology can be easily developed, and defini-
tive clinical studies can be performed to reestablish the
potential role for coronary sinus retroperfusion in our prac-
tice today. In our current environment of constant evolving
technology, forward progress might still be achieved by
using a backward technique.
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